Profil
Nader Motamedy is a Managing Partner at Safar Partners.
Prior to founding Safar, and until January 1, 2018, Nader was Senior Founding Partner, Chairman, and CEO of Caspian Private Equity (“CPE”), with over $3 billion under management.
He led the Investment Team and was a member of the Investment Committee and responsible for the strategic direction as well as the development and management of the firm.
During 2018, Nader was Vice Chairman of the Board of Managers of CPE.
Prior to and concurrent to that, until January 2012, Nader was a Founding Partner and member of the Board of Managers of Caspian Capital Management, LLC (“CCM”) which managed as much as $2.2 billion of alternative assets, including fixed income relative value portfolios and quantitative trading strategies.
CCM also provided non-discretionary consulting on as much as $3 billion in structured products on funds of hedge fund programs.
Nader began his investment career at Morgan Stanley in 1985 and worked at Prudential Securities and CDC Investment Management Corporation prior to founding CCM.
Nader holds an MBA from Boston College and a BS in Mechanical Engineering from Boston University.
He serves on various company and fund advisory boards.
In addition to other community engagements, he is also actively involved in several youth assistance and development projects.
Nader was instrumental in establishing the Paris St. Germain professional soccer team youth development program and its Foundation in the United States to help underprivileged youth achieve their athletic as well as academic potential.
He is also a senior advisor to Inter Campus, the philanthropic arm of Inter Milan soccer team in New York as well as the Youri Djorkaeff Foundation.
Nader is a member of the Directors Council at the Whitney Museum of Art.
He is also a member of the Tiger 21 organization in Boston, MA.
Postes actifs de Nader Motamedy
| Sociétés | Poste | Début |
|---|---|---|
Safar Partners LLC
 Safar Partners LLC Investment ManagersFinance Safar Partners LLC (Safar Partners) is a venture capital firm founded in 2019 by Nader Motamedy. The firm is headquartered in Cambridge, Massachusetts. | Fondateur | 01/01/2019 |
Aramis Biosciences, Inc.
 Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Directeur/Membre du Conseil | - |
Anciens postes connus de Nader Motamedy
| Sociétés | Poste | Fin |
|---|---|---|
Caspian Private Equity LLC
 Caspian Private Equity LLC Investment ManagersFinance Caspian Private Equity LLC is a private equity firm founded in 2008.The firm is headquartered in New York. | Directeur Général | 13/12/2018 |
Caspian Capital Management LLC
 Caspian Capital Management LLC Investment ManagersFinance Founded in 2000, Caspian Capital Management LLC is a registered investment advisor located in New York City. They are a wholly-owned subsidiary of Natixis Global Asset Management SA. The firm manages alternative fixed-income, fund-of-funds, private equity and real estate portfolios for institutional clients. | Portfolio Manager-Fixed Income | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Caspian Capital Management LLC
Caspian Capital Management LLC Investment ManagersFinance Founded in 2000, Caspian Capital Management LLC is a registered investment advisor located in New York City. They are a wholly-owned subsidiary of Natixis Global Asset Management SA. The firm manages alternative fixed-income, fund-of-funds, private equity and real estate portfolios for institutional clients. | Finance |
Caspian Private Equity LLC
Caspian Private Equity LLC Investment ManagersFinance Caspian Private Equity LLC is a private equity firm founded in 2008.The firm is headquartered in New York. | Finance |
Safar Partners LLC
Safar Partners LLC Investment ManagersFinance Safar Partners LLC (Safar Partners) is a venture capital firm founded in 2019 by Nader Motamedy. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Aramis Biosciences, Inc.
Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Health Technology |
